Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $72.82 USD
Change Today -0.24 / -0.33%
Volume 2.0M
As of 8:04 PM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

ventas inc (VTR) Snapshot

Open
$74.06
Previous Close
$73.06
Day High
$74.06
Day Low
$72.51
52 Week High
01/28/15 - $81.93
52 Week Low
09/24/14 - $60.63
Market Cap
24.1B
Average Volume 10 Days
1.8M
EPS TTM
$1.75
Shares Outstanding
330.9M
EX-Date
03/4/15
P/E TM
41.7x
Dividend
$3.16
Dividend Yield
3.36%
Current Stock Chart for VENTAS INC (VTR)

ventas inc (VTR) Related Businessweek News

No Related Businessweek News Found

ventas inc (VTR) Details

Ventas, Inc. is a publicly owned real estate investment trust. The firm engages in investment, management, financing, and leasing of properties in the healthcare industry. It invests in the real estate markets of the United States and Canada. The firm primarily invests in healthcare-related facilities including hospitals, skilled nursing facilities, senior housing facilities, medical office buildings, and other healthcare related facilities. Ventas, Inc. was founded in 1983 and is based in Chicago, Illinois with additional offices in Irvine, California; Louisville, Kentucky; Charlotte, North Carolina; and Dallas, Texas.

479 Employees
Last Reported Date: 02/13/15
Founded in 1983

ventas inc (VTR) Top Compensated Officers

Chairman, Chief Executive Officer, Member of ...
Total Annual Compensation: $1.1M
President
Total Annual Compensation: $648.9K
Chief Financial Officer, Acting Chief Account...
Total Annual Compensation: $143.8K
Executive Vice President of Medical Property ...
Total Annual Compensation: $461.4K
Chief Administrative Officer, Executive Vice ...
Total Annual Compensation: $500.6K
Compensation as of Fiscal Year 2014.

ventas inc (VTR) Key Developments

Ventas, Inc. Reports Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2015; Provides Earnings Guidance for the Second Quarter and Full Year 2015

Ventas, Inc. reported unaudited consolidated earnings results for the first quarter ended March 31, 2015. For the quarter, the company’s normalized funds from operations increased 20% to $387.5 million, from $323.4 million for the comparable 2014 period. Normalized FFO per diluted common share grew 8% to $1.18 as compared to $1.09 for the comparable 2014 period. Weighted average diluted shares outstanding increased to 329.2 million, compared to 296.2 million in 2014. Net income attributable to common stockholders was $120.4 million, or $0.37 per diluted common share. Net income attributable to common stockholders for the quarter ended March 31, 2014 was $121.0 million, or $0.41 per diluted common share. Total revenues were $884,024,000 compared to $741,470,000 a year ago. Income from continuing operations was $114,544,000 compared to $117,243,000 a year ago. Income before income from unconsolidated entities, income taxes, discontinued operations, real estate was $107,545,000 compared to $120,428,000 a year ago. Net cash provided by operating activities was $344,169,000 compared to $284,421,000 a year ago. Development project expenditures were $33,467,000 compared to $23,948,000 a year ago. Capital expenditures were $21,171,000 compared to $16,134,000 a year ago. Net operating income was $535,923,000 compared to $450,186,000 a year ago. Adjusted Pro Forma EBITDA was $505,983,000. Adjusted Pro Forma EBITDA annualized was $2,023,932,000. The company currently expects its 2015 normalized FFO per diluted share to increase to a range between $4.67 and $4.75. This updated guidance range represents 4%to 6% growth in normalized FFO per share over 2014. The company currently expects its 2015 NAREIT FFO per diluted share to range between $4.47 and $4.59, due principally to deal costs related to its investment activity. The company’ second quarter 2015 normalized FFO per diluted share growth is expected to be below this full-year growth range due to timing of dispositions, reinvestments and fee income.

Ventas Seeks Acquisitions

Ventas, Inc. (NYSE:VTR) is looking for acquisition opportunities. Ventas will drive growth and create value through acquisitions and active asset management, including redevelopment.

Ventas, Inc. to Report Q1, 2015 Results on Apr 24, 2015

Ventas, Inc. announced that they will report Q1, 2015 results at 9:00 AM, Eastern Standard Time on Apr 24, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VTR:US $72.82 USD -0.24

VTR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Brookdale Senior Living Inc $37.33 USD +0.59
HCP Inc $42.45 USD -0.12
Health Care REIT Inc $75.86 USD +0.04
Omega Healthcare Investors Inc $38.53 USD +0.24
Senior Housing Properties Trust $21.41 USD +0.08
View Industry Companies
 

Industry Analysis

VTR

Industry Average

Valuation VTR Industry Range
No financial data is available for VTR.
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VENTAS INC, please visit www.ventasreit.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.